ABO and COVID-19: However, divergent results are still coming forth with respect to the role of the ABO blood groups as a risk marker for COVID-19 severity linked to possible comorbidities and methodological differences as well as population differences in tissue receptors associated with SARS-CoV-2 infection (4, 13, 17–19).